MMP7 and interstitial lung disease: Doyle et al. conducted a study which might help diagnose RA-ILD in the subclinical phase by discovering that a biomarker profile consisting of MMP-7, activation-regulation chemokines, and surfactant protein D (SP-D) is consistent with the development of ILD in RA patients [49,52,53].